Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

People without Celiac disease: Gluten Abandonment do not bring any Benefit for the Heart (2017) Zopf Y Journal article Letter to the Editor on "LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations". Ultraschall in Med 2016; 37: 627-634 (2017) Strobel D, Schellhaas B Journal article, Letter Evaluation of meaningful change in bowel move frequency for patients with carcinoid syndrome (2017) Pavel ME, Gable J, Kulke MH, Bergsland E, Anthony LB, Caplin ME, Oberg KE, et al. Conference contribution Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide autogel/depot 120mg in the CLARINET open-label extension (2017) Cwikla JB, Wolin EM, Pavel ME, Phan AT, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution Impairment of gustatory and olfactory senses in plaque psoriasis (2017) Rueter P, Gruenthaler V, Zopf Y, Sticherling M Conference contribution Immunoregulatory role of NFAT-interacting protein (NIP) 45 in adaptive and innate immune responses in allergic asthma (2017) Koch S, Maeding N, Karwot R, Mirzakhani H, Springel R, Mittler S, Zimmermann T, et al. Conference contribution Dual role of the mycobacterial cord factor TDM in cross-regulation of macrophage responses to IFN gamma (2017) Killy B, Huber A, Ekici AB, Wirtz S, Dalpke A, Lang R Conference contribution Analysis of shear wave elastography and serum autotaxin as novel non-invasive markers of liver fibrosis in patients with autoimmune hepatitis - a prospective study (2017) Janik MK, Kruk B, Kostrzewa K, Raszeja-Wyszomirska J, Wolf K, Lammert F, Kremer A, et al. Conference contribution Apremilast Prevents Intestinal Inflammation in Colitis Models via Influencing Epithelial Barrier (2017) Weigmann B, Popp V, Neurath M, Horan G, Schafer P Conference contribution Baseline characteristics of Crohn's disease patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (02) (2017) Siegel CA, Lichtenstein G, Siegmund B, Lewis JD, Wolf D, Louis E, Sebastian S, et al. Conference contribution